Medicare Enrolled

Dr. Purushottam Mitra, M.D.

Pulmonary Disease · Ocala, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1834 SW 1ST AVE, Ocala, FL 34471
3527325552
In practice since 2006 (19 years)
NPI: 1679536528 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mitra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mitra? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mitra

Dr. Purushottam Mitra is a pulmonary disease in Ocala, FL, with 19 years in practice. Based on federal Medicare data, Dr. Mitra performed 1,955 Medicare services across 1,506 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mitra received a total of $10,260 from 46 pharmaceutical and/or device companies across 402 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mitra is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 32% volume in FL$ $10,260 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,955
Medicare services
Top 32% in FL for pulmonary disease
1,506
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~103 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity479$96$181
Office visit, established patient (30-39 min)236$97$190
Initial hospital admission, high complexity175$139$269
Critical care, first 30-74 min169$174$402
Test to measure expiratory airflow and volume changes before and after medication administration106$30$88
Test to examine how well the lungs exchange gases105$44$67
Hospital follow-up visit, moderate complexity88$64$120
Test to determine lung volumes using sensors68$42$65
Artery puncture collection of blood sample46$20$40
Carboxyhemoglobin (protein) level46$12$25
Blood gases measurement, with o2 saturation46$77$90
Methemoglobin (hemoglobin) analysis, quantitative46$8$9
Blood potassium level46$5$8
Blood sodium level46$5$8
Blood count, hemoglobin46$2$5
Test for exercise-induced lung stress42$25$60
New patient office visit (45-59 min)42$125$250
Test to determine lung volumes using gas dilution or washout37$34$65
Sleep study in sleep lab (6 years or older)33$470$1,000
Office visit, established patient, complex (40-54 min)31$140$268
Sleep study in sleep lab with continuous airway pressure (6 years or older)22$492$1,200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,260
Total received (2018-2024)
Avg $1,466/year across 7 years
Top 20% in FL for pulmonary disease
46
Companies
402
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,744 (95.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$516 (5.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,689
2023
$947
2022
$2,500
2021
$1,055
2020
$1,156
2019
$1,423
2018
$1,490

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$2,598
AstraZeneca Pharmaceuticals LP
$1,002
Intuitive Surgical, Inc.
$939
Boehringer Ingelheim Pharmaceuticals, Inc.
$767
Grifols USA, LLC
$606
Philips Electronics North America Corporation
$531
INTUITIVE SURGICAL, INC.
$500
Genentech USA, Inc.
$378
GENZYME CORPORATION
$320
Regeneron Healthcare Solutions, Inc.
$239
Takeda Pharmaceuticals U.S.A., Inc.
$204
United Therapeutics Corporation
$189
Watermark Medical, Inc.
$181
ABIOMED
$161
Pulmonx Corporation
$149
Actelion Pharmaceuticals US, Inc.
$138
La Jolla Pharmaceutical Company
$119
Shire North American Group Inc
$114
Electromed, Inc.
$107
Mylan Specialty L.P.
$92
Bayer HealthCare Pharmaceuticals Inc.
$88
Sunovion Pharmaceuticals Inc.
$86
Ethicon Inc.
$85
Maquet Cardiovascular U.S. Sales, L.L.C.
$65
Novartis Pharmaceuticals Corporation
$63
Insmed, Inc.
$60
Amgen Inc.
$51
Axsome Therapeutics, Inc.
$51
Mallinckrodt Hospital Products Inc.
$39
Tactile Systems Technology Inc
$33
Jazz Pharmaceuticals Inc.
$32
JAZZ PHARMACEUTICALS INC.
$32
3B Medical, Inc.
$29
Covis Pharma GmBH
$26
Avadel CNS Pharmaceuticals, LLC
$22
Harmony Biosciences Llc
$20
Alexion Pharmaceuticals, Inc.
$17
Janssen Pharmaceuticals, Inc
$16
Allergan Inc.
$16
Melinta Therapeutics, Inc.
$15
Inogen, Inc.
$15
PFIZER INC.
$14
Teva Pharmaceuticals USA, Inc.
$13
Fisher & Paykel Healthcare Inc
$12
Circassia Pharmaceuticals Inc
$11
Breathe Technologies, Inc.
$11
Top 3 companies account for 44.2% of total payments
Associated products mentioned in payments ›
(2809) Trilogy 100 · (8874) InCourage · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · ARES HOME SLEEP TESTING DEVICE · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · Baxdela · CARDIOHELP · CHANTIX · CHARTIS CATHETER · CINQAIR · CUVITRU · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · Esbriet · FASENRA · Flexitouch Plus · GIAPREZA · GLASSIA · IMFINZI · Impella · InogenOne · LIFE2000 · LONHALA MAGNAIR · LUMRYZ · LUNA · Monarch Platform · NUCALA · OFEV · OPSUMIT · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · Perforomist · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · Utibron · WAKIX · XARELTO · XOLAIR · XYREM · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $525 per 100 Medicare services performed
Looking for a pulmonary disease in Ocala?
Compare pulmonary diseases in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
9
Per 100K population
2.3
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mitra is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 20%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mitra experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Mitra performed 479 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mitra receive payments from pharmaceutical companies?
Yes. Dr. Mitra received a total of $10,260 from 46 companies across 402 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mitra's costs compare to other pulmonary diseases in Ocala?
Dr. Mitra's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mitra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →